Profound Medical Corp.

NASDAQ:PROF

Medical - Devices

Healthcare
$6.59 +4.11%

+$0.27 today

Market cap
$241.37M
Beta
0.52
P/E (TTM)
-6.3
EPS (TTM)
-$1.07
52W Low $3.76High $8.95

Volume 0.10M

Average 0.12M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$38.88M

FY 2025 · Annual

Investing Cash Flow

-$246,236.00

FY 2025 · Annual

Financing Cash Flow

$41.86M

FY 2025 · Annual

-23.5% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(30.7M)(28.67M)(28.32M)(27.82M)(42.57M)
Depreciation & Amortization1.88M1.6M929K936K569.8K
Deferred Income Tax00000
Stock-Based Compensation7.21M4.24M3.42M2.58M5.49M
Change in Working Capital(877K)(5.63M)540K591K(1.74M)
Accounts Receivables2M(1.42M)(956K)186K(175.01K)
Inventory(2.49M)(1.86M)353K656K(2.87M)
Accounts Payables(356K)(566K)1.35M815K384.62K
Other Working Capital(26K)(1.78M)(211K)(1.07M)918.81K
Other Non-Cash Items132K2.66M828K255K(622.65K)
Operating Cash Flow(22.36M)(25.8M)(22.61M)(23.45M)(38.88M)
Capital Expenditures(593K)000(179.08K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(561K)00091.63K
Investing Cash Flow(593K)000(246.24K)
Debt Repayment(386K)6.92M(912K)(2.56M)(1.33M)
Common Stock Issued00062.11M43.19M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities6.33M114K2.67M(4.85M)0
Financing Cash Flow5.95M7.03M1.76M54.7M41.86M
Effect of Forex Changes244K(1.87M)549K(2.54M)2M
Net Change in Cash(16.76M)(20.64M)(20.3M)28.7M4.73M
Free Cash Flow(22.95M)(25.8M)(22.61M)(23.45M)(39.05M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$42.6M
+ D&A$569.8K
+ Stock-Based Comp$5.5M
+ Deferred Tax$0
- Working Capital-$1.7M
- Other Non-Cash-$622.6K
= Operating Cash Flow-$38.9M
- Capex-$179.1K
= Free Cash Flow-$39.1M

Analysis

FY2025 free cash flow is -$39.1M. FCF conversion is 91.7% of net income. Operating cash flow was -$38.9M, with capex of -$179.1K. The largest bridge item is Stock-Based Comp at $5.5M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportNov 3, 2026

Does PROF generate free cash flow?

Profound Medical Corp. (PROF) generated -$39.05M of free cash flow in fiscal 2025.

How much operating cash flow does PROF produce?

Operating cash flow was -$38.88M, before capital expenditures of $179,084.00.